Premium
Stereotactic Radiosurgery/Radiation Protectors
Author(s) -
Kim Owen
Publication year - 2004
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/j.1476-5810.2004.0045g.x
Subject(s) - amifostine , radiosurgery , medicine , radiation therapy , modalities , medical physics , radiation oncology , intensive care medicine , surgery , social science , sociology
Perhaps the greatest challenge facing oncologists is the need to spare normal tissues from the often severe side effects of cancer therapy. Whether one is dealing with surgery, chemotherapy, or radiation therapy – the three major braches of oncology cure attempts can be compromised by this need. Even successfully treated patients can experience long term problems related to their care. Efforts are underway to minimize morbidity in all of the modalities associated with cancer treatments. Two measures in the field of radiation therapy drawing both increased interest and widespread acceptance of its use are stereotactic radiosurgery and radiation protectors such as amifostine.